Brief: Lansen Pharmaceutical says unit entered into framework agreement with Natural Dailyheath
20/09/2016 10:26
Sept 20 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* Maximum value of transactions between parties contemplated
during term will be rmb80 million
* Unit entered into entrusted processing framework agreement
with natural dailyheath (bvi)
* Continuing Connected Transactions In Relation To The
Execution Of An Entrusted Processing Framework Agreement
Source text (http://bit.ly/2cE8tpY)
Further company coverage: 0503.HK
((Bangalore.newsroom@thomsonreuters.com ;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year